Page 102 - Sohini Das

Zydus Wellness gets a Complan boost, Sourav Ganguly's star power for brands

Over a year since the company acquired Complan, Glucon-D and Nycil, it is redrawing the marketing formula around its newly acquired brands

Multiplex chains on overdrive to add screens next financial year

Leading multiplex chain owner PVR Cinemas, which opened 83 screens during 2019-20, has now set a target of 120-130 screens for the next FY

Malls, multiplexes bear the brunt of coronavirus outbreak ahead of Holi

Holi will be celebrated on Tuesday across India. The four-day weekend starting Saturday would have come as a boon for retailers, malls and multiplex operators

From Baaghi 3 to Sooryavanshi, big Bollywood films face coronavirus heat

Film events such as IIFA 2020 have been postponed for now

Coronavirus panic, it's catching: What companies and individuals are doing

While businesses have taken a hit, the crisis has also uncovered a human side to the cold and abstract face of globalisation

Music streaming app Gaana aims to be operationally profitable in 3 years

The platform, which has a 45 million strong library, now has 152 million monthly active users

Coronavirus impact: Firms stare at prospect of airlifting raw materials

Pharma industry officials said the aerial route was the best option available to companies right now, given the congestion at Chinese ports.

Will double turnover with anti-diabetic bet, says Boehringer Ingelheim

Boehringer has expanded its field force to 570 representatives to boost their diabetes medicine sales that contributes nearly 75 per cent of the company's turnover

USFDA warnings: Concerns remain even as India fares better than US

According to the USFDA, India accounted for nearly 18 per cent of the active pharmaceutical ingredients (APIs) sourced by the US, while China accounted for 13 per cent

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

NPPA allows differential price for Meril's biodegradable cardiac stent

The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent

True North scouts for acquisitions in orthopaedics and gynaecology space

Now, True North is focussed on growing Integrace by buying other products, divisions or smaller companies. Integrace is clocking a 12-15 per cent growth

Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems

A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.

India scores better than US in regulatory action by USFDA in 2019

From FY15 to FY19, Indian manufacturers received fewer warning letters than Chinese counterparts

Share of drugs under price control dips in domestic pharma market

India follows a market-based mechanism for determining ceiling prices of medicines that are a part of the National List of Essential Medicines (NLEM)

Budget 2020: Healthcare sector allocation rises to Rs 69,000 crore

Ayushman Bharat gets a boost as hospitals to be developed under PPP mode; Jan Aushadhi scheme to be expanded to every district

Coronavirus threat: Medical device firms see opportunity with rising demand

But drug firms brace for supply disruptions

Demand for chronic illness medicines rising faster than acute drugs: Report

Long-term treatments like diabetes, high blood pressure and lipid-lowering drugs are classified into the chronic category

Three programmes afoot to find vaccines against new coronavirus

The latest strain of the virus, which has been reported from China's Wuhan province, is already creating ripples across the global health care circuit

Research to find vaccines for China coronavirus put on fast lane

So far the World Health Organisation (WHO) has not declared this as a global health emergency